Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Not all Roth withdrawals are qualified. This primer outlines which withdrawals meet the qualified distribution criteria and how to maximize tax efficiency.
19,626 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Bitcoin breaches the $61,000 mark as the crypto market today, july narrative shifts toward easing inflation, ETF flow...
Amazon stock fell about 3% on Friday as macro uncertainty and doubts about a $200B AI capital plan for 2026 weigh on ...
A fresh payroll report has spurred renewed doubt about U.S. job data. Wall street, analysts increasingly doubt the ac...
This week brought a sharp decline in lenz therapeutics stock plummeted as concerns about revenue growth and financing...
The Bank of England’s digital pound project has collided with political finance scrutiny, turning a tech plan into a ...
A leading AI company hints at a monumental goal: $9 trillion in market value. We explore what that could mean for inv...
A high profile event can reveal how big budgets behave. This article translates that spectacle into actionable person...
A Russian actor allegedly used forged ties to the Astor name to extract roughly $450 million from a Mexican billionai...
Bitcoin remains perched above the $62,000 level as traders rotate back into risk assets. Altcoins like HYPE and ADA l...
Today, bitcoin rips past $82,000 as oil prices slump on de-escalation headlines, fueling a wave of short-covering and...
A new poll finds a prevailing mood that founders would be disappointed by modern democracy. This sentiment is shaping...